Conference
Treatment of the Chronic Phase of Chronic Myeloid Leukemia with an Intermittent Schedule of Recombinant Interferon Alfa-2b and Cytarabine: Results from CALGB Study 9013
Authors
Silver RT; Peterson BL; Szatrowski TP; Powell BL; Stock W; Carroll AJ; Bloomfield CD; Schiffer CA; Larson RA
Volume
44
Pagination
pp. 39-48
Publisher
Informa UK Limited
Publication Date
January 1, 2003
DOI
10.1080/1042819021000040260
Conference proceedings
Leukemia & Lymphoma
Issue
1
ISSN
1042-8194
Associated Experts
Medical Subject Headings (MeSH)
AdultAgedAntineoplastic Combined Chemotherapy ProtocolsBlotting, SouthernCentral Nervous System DiseasesCytarabineDrug Administration ScheduleFemaleFollow-Up StudiesFusion Proteins, bcr-ablHumansInterferon alpha-2Interferon-alphaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMaleMiddle AgedRecombinant ProteinsSurvival Analysis